ArticleFrontiers in cellular and infection microbiology2024

Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors.

Zhenyun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.